斯达外科手术 STAA 深 沪
等待开盘 02-11 09:30:00 美东时间
17.30
-0.110
-0.63%
华盛通- 最 高17.66
- 今 开17.41
- 成交量 94.39万股
- 最 低 17.285
- 昨 收 17.41
- 总市值 8.61亿
- 52周最高 30.81
- 市盈率 静 --
- 换手率 1.90%
- 52周最低 14.69
- 委 比 -46.71%
- 总股本 4974.20万
- 历史最高 163.08
- 量 比 0.60
- 振 幅 2.15%
- 历史最低 4.48
- 每 手 1
- 风险率 4.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 生化基因(BIIB)获10家大行上调目标价！Hims & Hers Health遭花旗下调目标价从30美元降至16.5美元
今日重点评级关注：瑞杰金融：上调Lumexa Imaging Holdings评级至"强力买入"，目标价23美元；BTIG：维持Transocean"买入"评级，目标价从6美元升至10美元
02-10 10:29
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-09 21:25
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $19
Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $28 to $19.
02-09 19:57
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
STAAR Surgical Appoints Warren Foust And Deborah Andrews As Interim Co-CEOs, Effective Immediately
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction,
02-02 20:17
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs STAAR Surgical Company has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers effective February 1, 2026. The Board has formed a sear
02-02 20:02
Assessing Staar Surgical: Insights From 4 Financial Analysts
Ratings for Staar Surgical (NASDAQ:STAA) were provided by 4 analysts in the pas...
01-29 06:01
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Carvana and UnitedHealth on Wednesday. HIGHLIGHTS * Boeing BA.N : JP Morgan raises target price to $270
01-28 15:23
STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn
STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn STAAR Surgical Company has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing identifies Richard T. LeBuhn as a beneficial owner in the role
01-24 06:14
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
